After US, Germany bans export of Ranbaxy's Dewas plant drugs
In fresh overseas troubles, drugmaker Ranbaxy has been barred from exporting certain antibiotics produced at its Dewas plant to Germany for non-compliance to 'good manufacturing practice' norms.
Dec 03, 2014, 21:18 PM IST
Sun Pharma Q2 net profit up 15% at Rs 1,572 cr
Sun Pharma Thursday said its consolidated net profit rose by 15 percent to Rs 1,572 crore for the second quarter ended September 30.
Nov 13, 2014, 17:56 PM IST
Dr Reddy's Q2 net down 17% at Rs 574.1 cr
Net income during the period under review stood at Rs 3,587.81 crore as against Rs 3,357.45 crore in the year-ago period, Dr Reddy's Laboratories said in a filing to BSE.
Oct 29, 2014, 16:07 PM IST
Lupin Q2 net profit up 55% at Rs 630 crore
Drug major Lupin Tuesday posted 55.11 percent rise in its consolidated net profit at Rs 630.04 crore for the second quarter ended September 30, driven by robust sales in the US, Japan and domestic market.
Oct 28, 2014, 15:04 PM IST
Ranbaxy posts Q2 net profit of Rs 477.75 cr
Drug firm Ranbaxy Laboratories Tuesday reported a consolidated net profit of Rs 477.75 crore for the quarter ended September 30, 2014 on account of robust sales.
Oct 28, 2014, 14:34 PM IST
GVK Bio under scanner of European Drug Regulator
The European Medicines Agency (EMA) has started a review in connection with findings of alleged non-compliance with good clinical practice (GCP) at a facility owned by GVK Biosciences, a city-based Contract Research Organisation.
Oct 01, 2014, 17:29 PM IST
